11.13.26 -- Closing The CAR-T Access Gap With Hospital-Based Manufacturing

See how oncology sponsors are modernizing data flow, analytics, and cross-functional collaboration to support faster, more informed trial decisions without compromising quality.

Discover how leading IDS teams are using automation and standardized digital workflows to streamline protocol management, reduce errors, improve efficiency, and strengthen research operations.

Explore FDA expedited programs and learn how Fast Track, Breakthrough Therapy, RMAT, Priority Review, and more can help accelerate development and bring therapies to patients sooner.

Learn how a micro-FSP model and integrated biometrics team can scale from specialized support to a full-service solution, ensuring agility and consistency as clinical trial needs evolve.

Investigate the rare disease community from several angles: as a physician, a rare disease specialist, a patient advocate, and the parent of a child with a rare genetic condition.

Cell and gene therapy commercialization requires tailored logistics strategies. Consider nine recommendations covering site readiness, reimbursement gaps, packaging, testing, and coordination.

Uncover how this company is working to bring clinical trials to patients' homes, workplaces, and communities, enhancing accessibility across all trial phases.

Delve into why cryopreservation studies are so critical and how biopharmaceutical manufacturers can more easily navigate the complexities of this process.